The potential impact of the 13-valent conjugate pneumococcal vaccine on antibiotic resistance in pneumococci

Review

The potential impact of the 13-valent conjugate pneumococcal vaccine on antibiotic resistance in pneumococci

DOI: 10.1080/10158782.2011.11441462
Author(s): S Nzenze University of the Witwatersrand, Faculty of Health Science, , K Klugman University of the Witwatersrand, Faculty of Health Science, Respiratory and Meningeal Pathogens Research Unit, , S Madhi University of the Witwatersrand, Faculty of Health Science,

Abstract

The emergence of antibiotic-resistant Streptococcus pneumoniae strains is primarily due to a selection of resistant strains by antibiotic use. The majority of antibiotic-resistant pneumococcal strains exist as a limited number of serotypes, many of which are already included in a 7-valent pneumococcal conjugate vaccine (PCV7).

Get new issue alerts for Southern African Journal of Epidemiology and Infection